GlassScriptPhysician profile
Joseph J Chen
NPI 1639496953
$13,060.34
in general payments reported to CMS, 2019-2025
31 companies · $2,580 in 2025
The $2,580 reported for 2025 was more than what 90% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $992 · 2020: $537 · 2021: $1,336 · 2022: $2,941 · 2023: $2,204 · 2024: $2,471 · 2025: $2,580.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,237 · Entertainment: $16.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,237.24 |
| Entertainment | $16.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,584.62 | 2019-2025 | Rocklatan, Hydrus Microstent, Clareon Panoptix Pro |
| Abbvie INC. | $1,512.27 | 2022-2025 | Xen Glaucoma Treatment System, Alphagan P, Lumigan |
| Sight Sciences, INC. | $1,383.55 | 2020-2025 | Omni Surgical System, Sion Surgical Instrument |
| Allergan, INC. | $1,367.83 | 2019-2022 | |
| Glaukos Corporation | $993.21 | 2019-2024 | Istent Trabecular Micro-Bypass System Model Is3, Istent Infinite Trabecular Micro-Bypass System Model Is3, Gsw-Istentinjectwtrabecular Micro-Bypass System |
| Bausch & Lomb Americas INC. | $935.95 | 2022-2025 | Envista Mx60 Iol, Vyzulta, Envista Envy Iol |
| Nova Eye, INC. | $830.33 | 2024-2025 | |
| New World Medical,INC. | $585.35 | 2022-2023 | |
| Sun Pharmaceutical Industries INC. | $483.00 | 2019-2024 | Cequa |
| Aerie Pharmaceuticals, INC. | $358.00 | 2019-2021 | |
| Amgen INC. | $350.97 | 2024-2025 | Tepezza |
| Livanova USA, INC. | $348.30 | 2019-2022 | |
| Johnson & Johnson Surgical Vision, INC. | $294.36 | 2019-2025 | Amo Phaco Needle, Tecnis Iol |
| Horizon Therapeutics Plc | $265.55 | 2022-2023 | Tepezza |
| Biotissue Holdings INC. | $258.84 | 2023-2025 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $244.66 | 2021-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $172.75 | 2019-2021 | |
| Galderma Laboratories, L.P. | $145.25 | 2025 | Nemluvio |
| Visionix USA, INC | $131.58 | 2022 | |
| Ani Pharmaceuticals, INC. | $116.33 | 2025 | Purified Cortrophin Gel |
| Astellas Pharma US INC | $110.08 | 2023 | Izervay |
| Thea Pharma INC. | $79.71 | 2024-2025 | Iyuzeh |
| Akorn Operating Company LLC | $75.30 | 2021 | |
| Tarsus Pharmaceuticals, INC. | $62.17 | 2024-2025 | Xdemvy |
| Oyster Point Pharma, INC. | $61.25 | 2023-2024 | Tyrvaya, Ryzumvi |
| Rayner Intraocular Lenses Limited | $58.90 | 2024 | Rayone Spheric, Rayone Emv, Rayone Aspheric |
| Mallinckrodt Hospital Products INC. | $58.31 | 2022-2024 | Acthar |
| Optos, INC. | $52.26 | 2022-2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Ivantis, INC | $50.05 | 2021 | |
| Rxsight INC | $45.29 | 2023-2024 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Kala Pharmaceuticals, INC. | $44.32 | 2020-2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.